Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/19739
Type: Thesis
Title: Cellular and molecular mechanisms by which the insert negative isoform of the human calcitonin receptor regulates cell growth / by Liza-Jane Raggatt.
Author: Raggatt, L. J.
Issue Date: 2000
School/Discipline: Dept. of Orthopaedics and Trauma
Abstract: Calcitonin (CT) is a 32 amino acid peptide hormone, known to inhibit osteoclastic bone resorption by direct interaction with cell surface calcitonin receptors (CTR). This study aims to define the intracellular mechanisms by which CT treatment results in decreased cellular proliferation. Results show, for the first time, that the growth regulating actions of CT are receptor isoform specific. In addition, CT inhibition of cellular proliferation occurs by arresting cells in the G2 phase of the cell cycle via a p21 mediated mechanism, which is at least partially activated through the Erk1/2 Map Kinase pathway.
Dissertation Note: Thesis (Ph.D.)--University of Adelaide, Dept. of Orthopaedics and Trauma, 2000
Subject: Calcitonin.
Cells Growth.
Description: Bibliography: leaves 141-169.
xix, 170, [63] leaves, [49] leaves of plates : ill. (chiefly col.) ; 30 cm.
Provenance: This electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exception. If you are the author of this thesis and do not wish it to be made publicly available or If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at: http://www.adelaide.edu.au/legals
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf506.5 kBAdobe PDFView/Open
02whole.pdf14.12 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.